Accentuating the caveat emptor perspective with critical commentary on financial disclosure. I adopt a skeptical persona and look for chinks in the teflon coating of financial disclosure. My job is to identify financial warts. Perhaps a Black Swan. Disclosure: I do not hold positions in stocks mentioned for three trading days before or after blog post.
Thursday, May 11, 2006
UnitedHealth Group Sinking Ship
Huge restatement may be required to account for the suspect stock options. What is really needed is a new board. This one is completely incompetent and does not deserve anyone's trust. This may be achieved through a takeover. Lets see now if we shoot the board and several senior executives what is the underlying value of the business after some ridiculous legal costs. Wonder if the directors liability insurance is still in force?